Monday, June 23, 2008 2:09:26 PM
Nice, what about POSC?
POSC
Positron Corporation Receives Positive Feedback at Society of Nuclear Medicine Meeting
HOUSTON, Jun 19, 2008 (BUSINESS WIRE) -- Positron Corporation (OTC: POSC) (the "Company") recently displayed their molecular imaging and automated radioisotope dose drawing systems at the Society of Nuclear Medicine Meeting in New Orleans, Louisiana. Approximately 3,900 attendees and over 180 exhibiting companies attended the meeting. The Society of Nuclear Medicine meeting is the world's largest event focused exclusively on the latest developments in molecular imaging technology and nuclear medicine based products and services.
"We received a great deal of positive feedback on our recent acquisition of Dose Shield Corporation and the integration of our product portfolio under one brand allowing for the sale of a turn-key solution encompassing imaging system, dose dispensing system, radiopharmaceutical and disease management software," stated Joe Oliverio, President of Positron. "Of particular note," continued Mr. Oliverio, "potential customers were pleasantly surprised to hear of our upcoming market release of an economically priced PET system that is design optimized for cardiology applications We are not aware of any other company selling a PET only into the USA market. We look forward to meeting the demand for a more economical product in cardiac PET, and our goal is to be delivering devices immediately after receiving our FDA 510k approval."
About Positron Corporation
Positron Corporation is a growing healthcare company offering cardiac molecular imaging solutions that will transform the delivery of healthcare through radiopharmaceutical development, advancing imaging technology and by introducing unique disease management applications into the market. Positron Corporation designs, manufactures and sells SPECT, PET and automated dose delivery devices in to the Nuclear Medicine market. Additional information may be found at http://www.positron.com/.
For any additional information contact Positron's President, Joe Oliverio at (281) 492-7100.
SOURCE: Positron Corporation
CONTACT: Positron
Joe Oliverio at (281) 492-7100
POSC
Positron Corporation Receives Positive Feedback at Society of Nuclear Medicine Meeting
HOUSTON, Jun 19, 2008 (BUSINESS WIRE) -- Positron Corporation (OTC: POSC) (the "Company") recently displayed their molecular imaging and automated radioisotope dose drawing systems at the Society of Nuclear Medicine Meeting in New Orleans, Louisiana. Approximately 3,900 attendees and over 180 exhibiting companies attended the meeting. The Society of Nuclear Medicine meeting is the world's largest event focused exclusively on the latest developments in molecular imaging technology and nuclear medicine based products and services.
"We received a great deal of positive feedback on our recent acquisition of Dose Shield Corporation and the integration of our product portfolio under one brand allowing for the sale of a turn-key solution encompassing imaging system, dose dispensing system, radiopharmaceutical and disease management software," stated Joe Oliverio, President of Positron. "Of particular note," continued Mr. Oliverio, "potential customers were pleasantly surprised to hear of our upcoming market release of an economically priced PET system that is design optimized for cardiology applications We are not aware of any other company selling a PET only into the USA market. We look forward to meeting the demand for a more economical product in cardiac PET, and our goal is to be delivering devices immediately after receiving our FDA 510k approval."
About Positron Corporation
Positron Corporation is a growing healthcare company offering cardiac molecular imaging solutions that will transform the delivery of healthcare through radiopharmaceutical development, advancing imaging technology and by introducing unique disease management applications into the market. Positron Corporation designs, manufactures and sells SPECT, PET and automated dose delivery devices in to the Nuclear Medicine market. Additional information may be found at http://www.positron.com/.
For any additional information contact Positron's President, Joe Oliverio at (281) 492-7100.
SOURCE: Positron Corporation
CONTACT: Positron
Joe Oliverio at (281) 492-7100
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
